CDKN2A and pancreatic neoplasm: Several molecular alterations were identified, such that pancreatic cancer is now perceived as a genetic disease characterised by the sequence of oncogenic K-ras activation, inactivation of the tumour suppressor p16INK4a, and inactivation of the tumour suppressors p53 and/or DPC4.